Examining the impact of COVID-19 on RSV-related emergency visits in children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the effects of the COVID-19 pandemic on the incidence of bronchiolitis and respiratory syncytial virus (RSV) presentations in emergency departments. It focuses on children under two years of age who exhibit symptoms of bronchiolitis or lower respiratory tract infections. The study aims to understand how the absence of RSV during the pandemic may influence future cases as restrictions are lifted. By analyzing emergency department visits, the research seeks to provide insights into the potential resurgence of bronchiolitis in the post-pandemic period.

Why it matters

Who can join: the full rules

Inclusion Criteria:

i) Children under two years of age presenting to participating emergency departments with clinical features of:

* Bronchiolitis (cough, tachypnoea or chest recession, and wheeze or crackles on chest auscultation) or
* Lower Respiratory Tract infection or
* Afirst episode of acute viral wheeze.

Exclusion Criteria:

i) Children with previous episodes of wheeze responsive to bronchodilator (suggesting an underlying diagnosis of recurrent wheeze of early childhood)

Where it's running

• University Hospitals of Leicester NHS Trust
  Leicester, United Kingdom Recruiting

Study contacts

• Principal investigator: Damian Roland, BMBS PhD — University Hospitals, Leicester
• Study coordinator: Damian Roland, BMBS PhD
• Email: dr98@leicester.ac.uk
• Phone: 07950891367

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Optimising Antibiotic Use for Paediatric LRTIs in Africa

  This study tests whether using point-of-care CRP tests together with the PREPARE score can safely reduce antibiotic use in infants aged 2–24 months with lower respiratory infections in a Johannesburg hospital.

  Recruiting University of Witwatersrand, South Africa · Johannesburg, Gauteng · NCT07841691

• RSV+HMPV protein shot for adults 60 and older

  A single shot of a two-virus vaccine is being tested in adults 60+ to see if it can prevent RSV and hMPV infections compared with placebo.

  Recruiting at 21 sites Phase 2 Sanofi · Bruse, Australian Capital Territory and 20 other locations · NCT07810010

• Seawater nasal sprays for relief of nasal and sinus symptoms

  This project will test four seawater nasal sprays to see if they help infants, children, adults, and pregnant or breastfeeding people with acute or chronic nasal and sinus symptoms.

  Recruiting at 32 sites Laboratoire de la Mer · Bordeaux and 31 other locations · NCT07262450

• Real-world safety monitoring of Beyfortus (nirsevimab) in Korean infants and toddlers

  This program follows children up to 24 months in Korea who receive Beyfortus to see if the medicine is safe when used in routine care.

  Recruiting Sanofi · Hwaseong-si, Gyeonggi-do · NCT07200206

• Understanding how genetics affect bronchodilator response in children with bronchiolitis

  This study is testing how genetics might affect how well bronchodilator treatments work for young children with bronchiolitis.

  Recruiting Phase 3 Nemours Children's Clinic · Orlando, Florida · NCT06946264

• Evaluating chest physiotherapy for infants with bronchiolitis

  This study tests if chest physiotherapy given by mothers can help infants under 12 months with bronchiolitis feel better compared to just standard hospital care.

  Recruiting Hawler Medical University · Erbil, Kurdistan · NCT06862895

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.